FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to microbiology. Described is the application of ghosts of bacteria E.coli for the stimulation of innate immune response, where the innate immune response is stimulated by the induction of expression and/or release of at least one innate immunity modulator, selected from the group, consisting of molecules of antimicrobial defence, proinflammatory cytokines, reactive nitrogen species (RNS) and reactive oxygen species (ROS).
EFFECT: described is the application of bacterial ghosts of Ecoli for the stimulation of innate immune response.
21 cl, 9 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| POLYPEPTIDE AND IMMUNE MODULATION | 2014 |
|
RU2682651C2 |
| NEW BACTERIUM AND ITS EXTRACTS AND THEIR APPLICATION IN THERAPY | 2011 |
|
RU2615140C2 |
| DNA COMPOSITION FOR INDUCING IMMUNE RESPONSE ON TUMOUR-ASSOCIATED MACROPHAGUES | 2007 |
|
RU2459631C2 |
| IMMUNOMODULATORY AND ANTINEOPLASTIC PEPTIDES | 2007 |
|
RU2430109C2 |
| USE OF ARSENIC COMPOUNDS TO TREAT TISSUE OR ORGAN REJECTION | 2013 |
|
RU2665362C2 |
| BACTERIA FOR APPLICATION AS PROBIOTICS USED WITH FOOD AND MEDICINE | 2012 |
|
RU2645466C2 |
| IMPROVED Bordetella pertussis VACCINES BASED ON MUTANT GLYCOSYLTRANSFERASES LPS | 2008 |
|
RU2542667C2 |
| USE OF A SYMBIOTIC CONSORTIUM OF PROBIOTIC LACTOBACILLI STRAINS ISOLATED FROM HUMAN MILK, WHICH HAS A BACTERICIDAL EFFECT ON MASTITIS-INDUCING PATHOGENS, FOR THE MANUFACTURE OF DRUGS FOR THE COMPLEX PREVENTION AND TREATMENT OF LACTATIONAL MASTITIS | 2022 |
|
RU2801119C1 |
| NEW DERIVATIVES OF SATN2 | 2015 |
|
RU2726124C2 |
| ANTIGEN AND PROTEIN TOXIC CODING NUCLEOTIDE SEQUENCE CARRIER MICROORGANISM | 2007 |
|
RU2447145C2 |
